Mitochondrial involvement in genetically determined transition metal toxicity. II. Copper toxicity

Chemico-Biological Interactions

Volumn 163, Issue 1-2, 2006, Pages 77-85

  Mehta, Rhea ^a   Templeton, Douglas M ^b   O'Brien, Peter J ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Copper; Cytotoxicity; Hepatotoxicity; Mitochondria

Indexed keywords

COPPER; MENKES PROTEIN; TRANSITION ELEMENT; WILSON DISEASE PROTEIN;

ARTICLE; CELL MEMBRANE; COPPER DEFICIENCY; CYTOTOXICITY; DEGENERATIVE DISEASE; GENETIC DISORDER; GENETICS; HOMEOSTASIS; HUMAN; LIVER TOXICITY; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; NEUROTOXICITY; NONHUMAN; PATHOGENESIS; WILSON DISEASE;

ANIMALS; BIOLOGICAL TRANSPORT; COPPER; HUMANS; METABOLISM, INBORN ERRORS; MITOCHONDRIA;

EID: 33750003457     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2006.05.011     Document Type: Article

References (63)

1. D.M. Templeton, P.J. O'Brien, X. Huang, Mitochondrial involvement in genetically determined transition metal toxicity: I iron toxicity, Chem. Biol. Interact., in press [E-Pub].
2. Arredondo M., and Nunez M.T. Iron and copper metabolism. Mol. Aspects Med. 26 (2005) 313-327
3. Bertinato J., and L'Abbe M.R. Copper modulates the degradation of copper chaperone for Cu, Zn superoxide dismutase by the 26 S proteosome. J. Biol. Chem. 278 (2003) 35071-35078
4. West E.C., and Prohaska J.R. Cu,Zn-superoxide dismutase is lower and copper chaperone CCS is higher in erythrocytes of copper-deficient rats and mice. Exp. Biol. Med. (Maywood) 229 (2004) 756-764
5. Balevska P.S., Russanov E.M., and Kassabova T.A. Studies on lipid peroxidation in rat liver by copper deficiency. Int. J. Biochem. 13 (1981) 489-493
6. Rossi L., Lippe G., Marchese E., De Martino A., Mavelli I., Rotilio G., and Ciriolo M.R. Decrease of cytochrome c oxidase protein in heart mitochondria of copper-deficient rats. Biometals 11 (1998) 207-212
7. Medeiros D.M., and Wildman R.E. Newer findings on a unified perspective of copper restriction and cardiomyopathy. Proc. Soc. Exp. Biol. Med. 215 (1997) 299-313
8. Rossi L., Lombardo M.F., Ciriolo M.R., and Rotilio G. Mitochondrial dysfunction in neurodegenerative diseases associated with copper imbalance. Neurochem. Res. 29 (2004) 493-504
9. Klevay L.M. Ischemic heart disease as deficiency disease. Cell Mol. Biol. (Noisy. -le-grand) 50 (2004) 877-884
10. Halliwell B., and Gutteridge J.M. Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol. 186 (1990) 1-85
11. Halliwell B., and Gutteridge J.M. Biologically relevant metal ion-dependent hydroxyl radical generation. An update. FEBS Lett. 307 (1992) 108-112
12. Prohaska J.R., and Gybina A.A. Intracellular copper transport in mammals. J. Nutr. 134 (2004) 1003-1006
13. Arciello M., Rotilio G., and Rossi L. Copper-dependent toxicity in SH-SY5Y neuroblastoma cells involves mitochondrial damage. Biochem. Biophys. Res. Commun. 327 (2005) 454-459
14. Sheline C.T., and Choi D.W. Cu2+ toxicity inhibition of mitochondrial dehydrogenases in vitro and in vivo. Ann. Neurol. 55 (2004) 645-653
15. Mercer J.F., and Llanos R.M. Molecular and cellular aspects of copper transport in developing mammals. J. Nutr. 133 (2003) 1481S-1484S
16. Elam J.S., Thomas S.T., Holloway S.P., Taylor A.B., and Hart P.J. Copper chaperones. Adv. Protein Chem. 60 (2002) 151-219
17. Banci L., Bertini I., Cantini F., Chasapis C.T., Hadjiliadis N., and Rosato A. A NMR study of the interaction of a three-domain construct of ATP7A with copper(I) and copper(I)-HAH1: the interplay of domains. J. Biol. Chem. 280 (2005) 38259-38263
18. Wijmenga C., and Klomp L.W. Molecular regulation of copper excretion in the liver. Proc. Nutr. Soc. 63 (2004) 31-39
19. Shim H., and Harris Z.L. Genetic defects in copper metabolism. J. Nutr. 133 (2003) 1527S-1531S
20. Vassiliev V., Harris Z.L., and Zatta P. Ceruloplasmin in neurodegenerative diseases. Brain Res. Brain Res. Rev. 49 (2005) 633-640
21. Templeton D.M. The importance of trace element speciation in biomedical science. Anal. Bioanal. Chem. 375 (2003) 1062-1066
22. Harris E.D. Basic and clinical aspects of copper. Crit. Rev. Clin. Lab. Sci. 40 (2003) 547-586
23. Carroll M.C., Girouard J.B., Ulloa J.L., Subramaniam J.R., Wong P.C., Valentine J.S., and Culotta V.C. Mechanisms for activating Cu- and Zn-containing superoxide dismutase in the absence of the CCS Cu chaperone. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 5964-5969
24. Dijkstra M., Kuipers F., van den Berg G.J., Havinga R., and Vonk R.J. Differences in hepatic processing of dietary and intravenously administered copper in rats. Hepatology 26 (1997) 962-966
25. Asad S.F., Singh S., Ahmad A., and Hadi S.M. Bilirubin/biliverdin-Cu(II) induced DNA breakage; reaction mechanism and biological significance. Toxicol. Lett. 131 (2002) 181-189
26. Feroci G., Fazio G., Fini A., and Zuman P. Interaction between Cu2+ ions and cholic acid derivatives followed by polarography. J. Pharm. Sci. 84 (1995) 119-125
27. Waldrop G.L., Palida F.A., Hadi M., Lonergan P.A., and Ettinger M.J. Effect of albumin on net copper accumulation by fibroblasts and hepatocytes. Am. J. Physiol. 259 (1990) G219-G225
28. Platonova N.A., Zhiguleva E.A., Tsymbalenko N.V., Mishchenko B.S., Vasin A.V., Zhivul'ko T.V., and Puchkova L.V. Age-related features of ceruloplasmin biosynthesis and distribution in rats. Ontogenez 35 (2004) 171-182
29. Harris Z.L., and Aceruloplasminemia. J. Neurol. Sci. 207 (2003) 108-109
30. Wagner G.S., and Tephly T.R. A possible role of copper in the regulation of heme biosynthesis through ferrochelatase. Adv. Exp. Med. Biol. 58 (1975) 343-354
31. Carr H.S., and Winge D.R. Assembly of cytochrome c oxidase within the mitochondrion. Acc. Chem. Res. 36 (2003) 309-316
32. Barrientos A., Barros M.H., Valnot I., Rotig A., Rustin P., and Tzagoloff A. Cytochrome oxidase in health and disease. Gene 286 (2002) 53-63
33. Williams D.M., Loukopoulos D., Lee G.R., and Cartwright G.E. Role of copper in mitochondrial iron metabolism. Blood 48 (1976) 77-85
34. Okado-Matsumoto A., and Fridovich I. Subcellular distribution of superoxide dismutases (SOD) in rat liver: Cu,Zn-SOD in mitochondria. J. Biol. Chem. 276 (2001) 38388-38393
35. Liochev S.I., and Fridovich I. Mutant Cu,Zn superoxide dismutases and familial amyotrophic lateral sclerosis: evaluation of oxidative hypotheses. Free Radic. Biol. Med. 34 (2003) 1383-1389
36. Vijayvergiya C., Beal M.F., Buck J., and Manfredi G. Mutant superoxide dismutase 1 forms aggregates in the brain mitochondrial matrix of amyotrophic lateral sclerosis mice. J. Neurosci. 25 (2005) 2463-2470
37. Ye B., Maret W., and Vallee B.L. Zinc metallothionein imported into liver mitochondria modulates respiration. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 2317-2322
38. Kondoh M., Inoue Y., Atagi S., Futakawa N., Higashimoto M., and Sato M. Specific induction of metallothionein synthesis by mitochondrial oxidative stress. Life Sci. 69 (2001) 2137-2146
39. Aschner M., Cherian M.G., Klaassen C.D., Palmiter R.D., Erickson J.C., and Bush A.I. Metallothioneins in brain-the role in physiology and pathology. Toxicol. Appl. Pharmacol. 142 (1997) 229-242
40. Cherian M.G., Jayasurya A., and Bay B.H. Metallothioneins in human tumors and potential roles in carcinogenesis. Mutat. Res. 533 (2003) 201-209
41. Costello L.C., Guan Z., Franklin R.B., and Feng P. Metallothionein can function as a chaperone for zinc uptake transport into prostate and liver mitochondria. J. Inorg. Biochem. 98 (2004) 664-666
42. Feng W., Cai J., Pierce W.M., Franklin R.B., Maret W., Benz F.W., and Kang Y.J. Metallothionein transfers zinc to mitochondrial aconitase through a direct interaction in mouse hearts. Biochem. Biophys. Res. Commun. 332 (2005) 853-858
43. Pourahmad J., and O'Brien P.J. A comparison of hepatocyte cytotoxic mechanisms for Cu2+ and Cd2+. Toxicology 143 (2000) 263-273
44. Vasin A.V., Klotchenko S.A., Platonova N.A., Tsymbalenko N.V., Babich V.S., and Puchkova L.V. Identification of the rat ceruloplasmin mRNA isoform putative coded of a protein localized in mitochondria. Mol. Biol. (Mosk) 39 (2005) 933-944
45. Saris N.E., and Skulskii I.A. Interaction of Cu+ with mitochondria. Acta Chem. Scand. 45 (1991) 1042-1046
46. Sokol R.J., Devereaux M.W., O'Brien K., Khandwala R.A., and Loehr J.P. Abnormal hepatic mitochondrial respiration and cytochrome c oxidase activity in rats with long-term copper overload. Gastroenterology 105 (1993) 178-187
47. Smeyers-Verbeke J., May C., Drochmans P., and Massart D.L. The determination of Cu, Zn, and Mn in subcellular rat liver fractions. Anal. Biochem. 83 (1977) 746-753
48. Lal S., and Sourkes T.L. Intracellular distribution of copper in the liver during chronic administration of copper sulfate to the rat. Toxicol. Appl. Pharmacol. 18 (1971) 562-572
49. Kumaratilake J.S., and Howell J.M. Intracellular distribution of copper in the liver of copper-loaded sheep-a subcellular fractionation study. J. Comp. Pathol. 101 (1989) 161-176
50. Haywood S., Simpson D.M., Ross G., and Beynon R.J. The greater susceptibility of North Ronaldsay sheep compared with Cambridge sheep to copper-induced oxidative stress, mitochondrial damage and hepatic stellate cell activation. J. Comp. Pathol. 133 (2005) 114-127
51. Kristensen D.B., Kawada N., Imamura K., Miyamoto Y., Tateno C., Seki S., Kuroki T., and Yoshizato K. Proteome analysis of rat hepatic stellate cells. Hepatology 32 (2000) 268-277
52. Mansouri A., Gaou I., Fromenty B., Berson A., Letteron P., Degott C., Erlinger S., and Pessayre D. Premature oxidative aging of hepatic mitochondrial DNA in Wilson's disease. Gastroenterology 113 (1997) 599-605
53. Gu M., Cooper J.M., Butler P., Walker A.P., Mistry P.K., Dooley J.S., and Schapira A.H. Oxidative-phosphorylation defects in liver of patients with Wilson's disease. Lancet 356 (2000) 469-474
54. Sternlieb I., Quintana N., Volenberg I., and Schilsky M.L. An array of mitochondrial alterations in the hepatocytes of Long-Evans cinnamon rats. Hepatology 22 (1995) 1782-1787
55. Uriu-Adams J.Y., and Keen C.L. Copper, oxidative stress, and human health. Mol. Aspects Med. 26 (2005) 268-298
56. Sheline C.T., Choi E.H., Kim-Han J.S., Dugan L.L., and Choi D.W. Cofactors of mitochondrial enzymes attenuate copper-induced death in vitro and in vivo. Ann. Neurol. 52 (2002) 195-204
57. Brewer G.J. Anticopper therapy against cancer and diseases of inflammation and fibrosis. Drug Discov. Today 10 (2005) 1103-1109
58. Beshgetoor D., and Hambidge M. Clinical conditions altering copper metabolism in humans. Am. J. Clin. Nutr. 67 (1998) 1017S-1021S
59. Eaton J.W., and Qian M. Interactions of copper with glycated proteins: possible involvement in the etiology of diabetic neuropathy. Mol. Cell Biochem. 234-235 (2002) 135-142
60. Lutsenko S., and Cooper M.J. Localization of the Wilson's disease protein product to mitochondria. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 6004-6009
61. Liu P.C., Chen Y.W., Centeno J.A., Quezado M., Lem K., and Kaler S.G. Downregulation of myelination, energy, and translational genes in Menkes disease brain. Mol. Genet. Metab. 85 (2005) 291-300
62. Keller R., Torta R., Lagget M., Crasto S., and Bergamasco B. Psychiatric symptoms as late onset of Wilson's disease: neuroradiological findings, clinical features and treatment. Ital. J. Neurol. Sci. 20 (1999) 49-54
63. Sokol R.J., Twedt D., McKim Jr. J.M., Devereaux M.W., Karrer F.M., Kam I., von Steigman G., Narkewicz M.R., Bacon B.R., and Britton R.S. Oxidant injury to hepatic mitochondria in patients with Wilson's disease and Bedlington terriers with copper toxicosis. Gastroenterology 107 (1994) 1788-1798